GRTSGritstone OncologyGRTS info
$0.55info-2.07%24h
Global rank24964
Market cap$52.29M
Change 7d-
YTD Performance-73.38%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Gritstone Oncology (GRTS) Stock Overview

    Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, a neoantigen-based immunotherapy, which is in Phase 2/3 clinical trials for the treatment of solid tumors, including microsatellite stable colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

    GRTS Stock Information

    Symbol
    GRTS
    Address
    5959 Horton StreetEmeryVille, CA 94608United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://gritstonebio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    510 871 6100

    Gritstone Oncology (GRTS) Price Chart

    -
    Value:-

    Gritstone Oncology Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.5484
    N/A
    Market Cap
    $52.29M
    N/A
    Shares Outstanding
    95.34M
    N/A
    Employees
    233.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org